TARRYTOWN, N.Y. (AP) _ Regeneron Pharmaceuticals Inc. (REGN) on Friday reported fourth-quarter net income of $1.2 billion.On a per-share basis, the Tarrytown, New York-based company said it had net income of $10.50. Earnings, adjusted for one-time gains and costs, came to $12.56 per share.The results topped Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $9.68 per share.The biopharmaceutical company posted revenue of $3.41 billion in the period, also exceeding Street forecasts. Seven analysts surveyed by Zacks expected $3.17 billion.For the year, the company reported profit of $4.34 billion, or $38.22 per share. Revenue was reported as $12.17 billion.This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on REGN at https://www.zacks.com/ap/REGNCopyright by Automated Insights, Inc. All rights reserved., source Associated Press News